Vishnu Suppiramaniam Selected Research

aniracetam

4/2008	Aniracetam reversed learning and memory deficits following prenatal ethanol exposure by modulating functions of synaptic AMPA receptors.
6/2007	Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vishnu Suppiramaniam Research Topics

Disease

17	Cognitive Dysfunction 01/2023 - 09/2007
16	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 06/2007
8	Memory Disorders (Memory Loss) 10/2023 - 04/2008
8	Parkinson Disease (Parkinson's Disease) 06/2021 - 01/2007
6	Neuroinflammatory Diseases 11/2021 - 01/2018
6	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021 - 03/2008
4	Fetal Alcohol Spectrum Disorders 02/2018 - 06/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 06/2016 - 07/2008
3	Inflammation (Inflammations) 01/2023 - 01/2016
3	Dementia (Dementias) 01/2023 - 03/2015
3	Insulin Resistance 01/2020 - 02/2012
2	Schizophrenia (Dementia Praecox) 01/2023 - 03/2010
2	Chemotherapy-Related Cognitive Impairment 01/2023 - 07/2021
2	Neoplasms (Cancer) 07/2021 - 07/2019
2	Seizures (Absence Seizure) 06/2021 - 01/2016
2	Brain Diseases (Brain Disorder) 01/2019 - 01/2018
2	Stroke (Strokes) 01/2019 - 01/2018
2	Movement Disorders (Movement Disorder) 06/2016 - 05/2012
2	Tremor (Tremors) 01/2010 - 11/2006
2	Erectile Dysfunction 09/2007 - 03/2007
1	Cardiotoxicity 01/2023
1	Amyloidosis 11/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Neuroblastoma 03/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Amyloid Plaque 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2015

Drug/Important Bio-Agent (IBA)

6	Neuroprotective AgentsIBA 10/2019 - 03/2007
5	Amyloid beta-PeptidesIBA 01/2023 - 06/2007
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2012 - 11/2006
4	AMPA Receptors (AMPA Receptor)IBA 07/2021 - 04/2008
4	Dopamine (Intropin)FDA LinkGeneric 06/2016 - 11/2009
3	PPAR gammaIBA 01/2023 - 03/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 07/2019
3	AcidsIBA 06/2021 - 09/2007
3	CytokinesIBA 10/2019 - 10/2018
3	LipopolysaccharidesIBA 10/2019 - 01/2018
3	Methamphetamine (Desoxyn)FDA LinkGeneric 06/2016 - 11/2009
3	Insulin (Novolin)FDA Link 03/2015 - 02/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 11/2019
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2023 - 03/2010
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2018
2	N-Methylaspartate (NMDA)IBA 06/2021 - 09/2007
2	Antidepressive Agents (Antidepressants)IBA 12/2020 - 01/2018
2	6alpha-ethyl-23(S)-methylcholic acidIBA 10/2019 - 10/2018
2	AdiponectinIBA 01/2019 - 01/2018
2	Nicotine FDA Link 02/2018 - 03/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2007
2	Rosiglitazone (Avandia)FDA Link 01/2018 - 03/2015
2	Glutamic Acid (Glutamate)FDA Link 05/2017 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 09/2015 - 02/2012
2	RotenoneIBA 03/2015 - 05/2012
2	Glutamate Receptors (Glutamate Receptor)IBA 02/2012 - 09/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2010 - 09/2007
2	aniracetamIBA 04/2008 - 06/2007
2	Ethanol (Ethyl Alcohol)IBA 04/2008 - 01/2008
2	Peptides (Polypeptides)IBA 03/2008 - 06/2007
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2007 - 03/2007
2	Sildenafil Citrate (Viagra)FDA Link 09/2007 - 03/2007
1	polysialyl neural cell adhesion moleculeIBA 10/2023
1	Cannabinoid Receptor AgonistsIBA 10/2023
1	CannabinoidsIBA 10/2023
1	AntioxidantsIBA 01/2023
1	phenyl-2-aminoethylselenide (PAESe)IBA 01/2023
1	PPAR deltaIBA 01/2023
1	polysialic acidIBA 01/2023
1	PPAR-gamma AgonistsIBA 01/2023
1	KynurenineIBA 11/2021
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 11/2021
1	CRISPR-Associated Protein 9IBA 11/2021
1	Cholinesterases (Cholinesterase)IBA 06/2021
1	Ketone BodiesIBA 06/2021
1	EnzymesIBA 06/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2020
1	LeptinIBA 01/2020
1	integrin-linked kinaseIBA 11/2019
1	ursodoxicoltaurineIBA 07/2019
1	AnthracyclinesIBA 07/2019
1	AdipokinesIBA 01/2019
1	Apolipoprotein E4IBA 01/2019
1	PiperazineIBA 03/2018
1	1-benzylpiperazineIBA 03/2018
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2018
1	Pioglitazone (Actos)FDA Link 01/2018
1	FPS-ZM1IBA 01/2018
1	zileuton (Zyflo)FDA Link 01/2018
1	Sirtuin 3IBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 05/2017
1	InsecticidesIBA 06/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016
1	Sodium Salicylate (Salicylate, Sodium)IBA 06/2016
1	Kainic Acid (Kainate)IBA 01/2016
1	Poly I-CIBA 01/2016
1	PMX-500FIIBA 03/2015

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2023 - 01/2007
1	Therapeutics 01/2023
1	Intranasal Administration 01/2023
1	Intraperitoneal Injections 01/2016